Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rate of Progression in USH2A-related Retinal Degeneration

NCT03146078 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03146078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rate of Progression in USH2A-related Retinal Degeneration
Lead sponsor
Jaeb Center for Health Research
Phase
Observational
Overall status
Active, not recruiting
Start date
August 11, 2017
Completion date
December 15, 2029
Enrollment
127 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

retinitis pigmentosa 39, usher syndrome, type 2a